Chronic lymphocytic leukaemia: from genetics to treatment

F Bosch, R Dalla-Favera - Nature reviews Clinical oncology, 2019 - nature.com
Chronic lymphocytic leukaemia (CLL), the most frequent type of leukaemia in adults, is a
lymphoproliferative disorder that is characterized by the expansion of monoclonal, mature …

[HTML][HTML] Targeting mitosis in cancer: emerging strategies

C Dominguez-Brauer, KL Thu, JM Mason, H Blaser… - Molecular cell, 2015 - cell.com
The cell cycle is an evolutionarily conserved process necessary for mammalian cell growth
and development. Because cell-cycle aberrations are a hallmark of cancer, this process has …

The molecular pathogenesis of chronic lymphocytic leukaemia

G Fabbri, R Dalla-Favera - Nature Reviews Cancer, 2016 - nature.com
Recent investigations have provided an increasingly complete picture of the genetic
landscape of chronic lymphocytic leukaemia (CLL). These analyses revealed that the CLL …

Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells

M Hudecek, MT Lupo-Stanghellini, PL Kosasih… - Clinical cancer …, 2013 - AACR
Purpose: The adoptive transfer of T cells modified to express a chimeric antigen receptor
(CAR) comprised of an extracellular single-chain antibody (scFV) fragment specific for a …

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

M Kulis, S Heath, M Bibikova, AC Queirós, A Navarro… - Nature …, 2012 - nature.com
We have extensively characterized the DNA methylomes of 139 patients with chronic
lymphocytic leukemia (CLL) with mutated or unmutated IGHV and of several mature B-cell …

The multidimensional role of the Wnt/β‐catenin signaling pathway in human malignancies

IS Hiremath, A Goel, S Warrier… - Journal of Cellular …, 2022 - Wiley Online Library
Several signaling pathways have been identified as important for developmental processes.
One of such important cascades is the Wnt/β‐catenin signaling pathway, which can regulate …

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Y Herishanu, P Pérez-Galán, D Liu… - Blood, The Journal …, 2011 - ashpublications.org
Chronic lymphocytic leukemia (CLL), an incurable malignancy of mature B lymphocytes,
involves blood, bone marrow, and secondary lymphoid organs such as the lymph nodes …

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

S Ponader, SS Chen, JJ Buggy… - Blood, The Journal …, 2012 - ashpublications.org
B-cell receptor (BCR) signaling is a critical pathway in the pathogenesis of several B-cell
malignancies, including chronic lymphocytic leukemia (CLL), and can be targeted by …

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or …

A Chanan-Khan, P Cramer, F Demirkan… - The Lancet …, 2016 - thelancet.com
Background Most patients with chronic lymphocytic leukaemia or small lymphocytic
lymphoma relapse after initial therapy. Bendamustine plus rituximab is often used in the …

ROR1: an orphan becomes apparent

TJ Kipps - Blood, The Journal of the American Society of …, 2022 - ashpublications.org
Since its initial identification in 1992 as a possible class 1 cell-surface receptor without a
known parent ligand, receptor tyrosine kinase–like orphan receptor 1 (ROR1) has stimulated …